SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp selloff and break below key support levels are dominating discussion, with traders pointing to leveraged-long liquidations and broader risk-off pressure across crypto and tech as possible contributors. The community is split between warnings of further downside and calls to buy an oversold dip or watch for support.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas reiterated that topline results from its Phase 3 REGAL trial of GPS in AML are expected in November after the trial reached its required event milestone, drawing attention to the pending binary readout. Traders are broadly excited about the prospect of positive data and a short squeeze, while speculation about a leak or buyout remains unconfirmed and skeptics stress that results have not been released and the trial outcome is uncertain.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints about work interruptions and concern that the prolonged disruption could damage trust or pressure the stock. Some traders speculated about a cyberattack, but the cause was not confirmed, and others questioned why shares held relatively steady.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs sharp decline toward the $1 support level amid a broader crypto selloff is dominating discussion, with traders pointing to Bitcoin weakness, inflation and rate concerns, and liquidations. Bears warn of further downside and question Ripples ability to provide catalysts, while some holders view the drop as a buying opportunity and continue accumulating.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Weakness in Ethereum and broader crypto-linked stocks is weighing on BitMine, while traders also criticize its underperformance and question managements spending, transparency, and buybacks. Some see the stocks discount to its crypto holdings as a buying opportunity, but bearish posts argue falling ETH prices can overwhelm any support from repurchases.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure as Bitcoin and broader crypto markets sell off, with traders highlighting COINs repeated new lows and weak performance even when Bitcoin stabilizes. Bearish calls dominate, though some see the decline as oversold and are buying the dip.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stocks to buy: Sagar Doshi suggests Laurus Labs, Data Patterns, Syrma SGS shares to buy

On April 7, Nifty 50 and Sensex declined due to Middle East conflict concerns and a US deadline for Iran. Nifty 50 fell 0.65% and Sensex 0.64%. Fourteen of 16 sectors dropped, while small-cap and mid-cap indices also fell, impacting India's economic growth.

Brief India: Quarterly Flipbook: Poised to inch up to double-digit earnings growth in FY26 and more

In this briefing: Quarterly Flipbook: Poised to inch up to double-digit earnings growth in FY26 NIFTY 50 Tactical Outlook After IMSC's March Index Review Clean Max: Leading The "Energy-As-A-Service" Revolution Laurus Labs: Shifting from ARV Concentration to Diversified CDMO Platform From Headcount to Agents: Structural Change in Indian IT Industry 1. Quarterly Flipbook: Poised to inch up to double-digit earnings growth in FY26 The aggregate performance of the Q3FY26 earnings season was robust as YoY PAT growth steadily improved to reach low double-digit level building up on the recovery witnessed in previous two quarters Aggregate revenue/PAT grew by 9%/13% YoY and 6%/8% QoQ respectively across the HSIE coverage (~257 stocks) Also, revenue and PAT grew by 7.1%/10.1% respectively in 9MFY26 Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Brief India: NIFTY 50 Tactical Outlook After IMSC's March Index Review and more

In this briefing: NIFTY 50 Tactical Outlook After IMSC's March Index Review Clean Max: Leading The "Energy-As-A-Service" Revolution Laurus Labs: Shifting from ARV Concentration to Diversified CDMO Platform From Headcount to Agents: Structural Change in Indian IT Industry Event Driven: IDFC First Bank’s ₹590 Cr Fraud~ Branch-Level Collusion Raises Governance Doubts 1. NIFTY 50 Tactical Outlook After IMSC's March Index Review As discussed in detail by Brian Freitas the IMSC of NSE Indices has announced the results of the March index review on Feb 23rd. There are no constituent changes forthe NIFTY Index (NIFTY INDEX) . The index is currently in a position from where it could rally higher, but seems to have encountered resistance in the 25700-25800 price area - BEARISH. 2. Clean Max: Leading The "Energy-As-A-Service" Revolution Clean Max is India's premier " Energy-as-a-Service" provider, commanding an 8% C&I market share and operating as a comprehensive decarbonization partner for global blue-chip corporations.

Brief Equities Bottom-Up: McBride plc - sustained private label profitability and more

In this briefing: McBride plc - sustained private label profitability Vaalco Energy (NYSE: EGY): Kossipo shines Clean Max: Leading The "Energy-As-A-Service" Revolution Applied Materials (Nasdaq: AMAT): Valuation Analysis Suggests Fair Value Near $431 Laurus Labs: Shifting from ARV Concentration to Diversified CDMO Platform 1. McBride plc - sustained private label profitability McBride’s H126 results confirm that for the third year running, demand for private label cleaning products remains at high levels, with private label volumes +0.9%, and Adj. EBIT margin a robust 6.6%. Management has confirmed that H2 has started in-line with expectations and that new contract wins across divisions underpin the positive outlook for H226 and into FY27E. Material costs are expected to remain flat and, with overhead costs under control, management is confident in meeting consensus expectations for FY26E of c.£64.7m Adj. EBIT. 2. Vaalco Energy (NYSE: EGY): Kossipo shines • New seismic over Kossipo in Côte d’Ivoire has further de‑risked the structure, increasing gross 2C resources from ~90 mmboe to ~102 mmboe. • With Canadian Natural Resources choosing not to participate in the development as it refocuses on Canada, VAALCO’s working interest rises from 27.39% to 60%, with PetroCI holding the balance as a paying partner. • This shift is highly material: VAALCO gains ~37 mmboe of additional WI 2C resources, becomes operator, and will control the development timeline. 3.

Brief Equities Bottom-Up: Vaalco Energy (NYSE: EGY): Kossipo shines and more

In this briefing: Vaalco Energy (NYSE: EGY): Kossipo shines Clean Max: Leading The "Energy-As-A-Service" Revolution Applied Materials (Nasdaq: AMAT): Valuation Analysis Suggests Fair Value Near $431 Laurus Labs: Shifting from ARV Concentration to Diversified CDMO Platform Begbies Traynor Group plc - BTG Consulting - a reassuringly good Q3 trading update 1. Vaalco Energy (NYSE: EGY): Kossipo shines • New seismic over Kossipo in Côte d’Ivoire has further de‑risked the structure, increasing gross 2C resources from ~90 mmboe to ~102 mmboe. • With Canadian Natural Resources choosing not to participate in the development as it refocuses on Canada, VAALCO’s working interest rises from 27.39% to 60%, with PetroCI holding the balance as a paying partner. • This shift is highly material: VAALCO gains ~37 mmboe of additional WI 2C resources, becomes operator, and will control the development timeline. 2. Clean Max: Leading The "Energy-As-A-Service" Revolution Clean Max is India's premier " Energy-as-a-Service" provider, commanding an 8% C&I market share and operating as a comprehensive decarbonization partner for global blue-chip corporations.

Laurus Labs Entering Multi-Year Growth Cycle After 875% Profit Surge; SFP Research Sees Over 10% Upside Potential 

Equity

Nifty Holds Below 26,000; Metals, Realty Shine While FMCG Drags

Stocktwits AMA: SEBI Analyst Vatsal Khemka Bullish On India’s Power, Infra & Port Plays

Reliance, NTPC, and Adani Power stood out as accumulation and growth plays, while Laurus Labs and Biocon were flagged for caution.



Breakout Stocks: SEBI Analyst Sees Upside In Laurus Labs And TD Power Systems

The analyst noted that Laurus Labs and TD Power Systems exhibit bullish technical setups and strong fundamentals.

From Laurus Labs To Alkem: SEBI Analysts Spot Bullish Setups In These Five Stocks For Short-Term Trades 

Stocks like MCX and Windlas Biotech are showing strong technical momentum, according to analysts. 

Laurus Labs Ltd. develops and manufactures active pharmaceutical ingredients for therapeutic areas of anti-retrovirals and hepatitis C. The company was founded by Dr. Satyanarayana Chava on September 19, 2005 and is headquartered in Hyderabad, India.

Laurus Labs Ltd.

Neutral Sentiment

<ul class="summary-bullets"><li>The Hyderabad-based pharma player posted stellar Q2, driven by strong CDMO and generics growth.</li><li>Analysts maintain a bullish outlook despite valuation concerns.</li><li>SFP Research set a short-term target of ₹1,000–₹1,030.</li></ul><p>Laurus Labs shares fell 3% in early trade on Friday, a day after the company reported a strong September quarter (Q2 FY26) earnings performance.</p><p>Revenue of ₹1,653 crore marked a 35% YoY growth, primarily driven by 53% growth in the CDMO segment (₹518 crore) and 28% growth in Generics (₹1,135 crore). Net profit of ₹195 crore represents an 875% YoY jump in Q2.​&nbsp;</p><p>SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/Sfpresearch">SFP Research</a> recommends ‘Buy’ for medium to long-term and ‘Hold’ for short-term, with a target price of ₹1,000-1,030 (6-month horizon). Laurus Labs is entering a strong growth cycle driven by its transformational CDMO business, which has emerged as the key earnings driver with sustained margin expansion.&nbsp;</p><p>Laurus’ positioning in the rapidly growing Indian CDMO market ($7.9 billion to $15.4 billion by 2033), coupled with the global ‘China Plus One’ tailwind, provides a multi-year growth runway, according to SFP Research.&nbsp;</p><h2 class="st-heading-2"><strong>Laurus Labs: Technical Outlook</strong></h2><p><a href="https://stocktwits.com/symbol/LAURUSLABS.NSE">Laurus Labs stock</a> successfully broke through resistance at the ₹920 levels and is consolidating near all-time highs. The analysts identified immediate support at ₹880-900, strong support at ₹840-860, and major support at ₹800-820. On the upside, immediate resistance is seen at ₹944 (52-week high), followed by ₹950-1000.</p><p>A decisive break above ₹950 can propel the stock toward ₹1,000-1,030 levels. They added that the uptrend remains intact as long as the stock trades above ₹840.&nbsp;</p><h2 class="st-heading-2"><strong>What’s Driving The Bullish Call?</strong></h2><p>Laurus Labs reported an exceptional 875% profit growth, demonstrating an operational turnaround. The CDMO business delivered 53% growth with robust pipeline of 110+ projects.&nbsp;</p><p>The analysts highlighted that the company’s investments in ADC, biologics, gene therapy position for future growth. Additionally, it enjoys strong institutional backing with 26% FII holding and increasing MF participation.</p><h2 class="st-heading-2"><strong>Valuation Concerns</strong></h2><p>SFP raised concerns about its stretched valuation at 100x PE versus fair value of 46x PE. However, given the strong momentum, superior execution, and margin expansion, they believe that the stock can sustain premium multiples in the near term.&nbsp;</p><h2 class="st-heading-2"><strong>What Should Traders Do?</strong></h2><p>For existing investors, they recommend holding positions with a stop-loss at ₹840-850. New investors should consider accumulating in 5-10% corrections toward the ₹850-880 support zones for better risk-reward.</p><p><stembedurl>https://stocktwits.com/Sfpresearch/message/633465180</stembedurl></p><h2 class="st-heading-2"><strong>What Is The Retail Mood On Stocktwits?</strong></h2><p>Data on Stocktwits showed that retail sentiment turned ‘bullish’ a day ago, following strong Q2 earnings performance amid ‘high’ message volumes.&nbsp;</p><figure class="image"><img style="aspect-ratio:732/94;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_24_102303_png_d5e1cb71c3.webp" alt="Screenshot 2025-10-24 102303.png" width="732" height="94"><figcaption><span style="background-color:#ffffff;color:#000000;font-family:Roboto,sans-serif;">Laurus Labs sentiment and message volume on Oct 24 as of 10:30 am IST. | source: Stocktwits</span></figcaption></figure><p>Laurus Labs shares have surged 50% year-to-date (YTD).</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

Photographer: Dhiraj Singh/Bloomberg via Getty Images

The Hyderabad-based pharma player posted stellar Q2, driven by strong CDMO and generics growth.

Current Price	2,439.30
Prev Close	2,400.00
Open	2,400.00
Dividend Yield	0.20%
50-Day Moving Average	2,076.48
Beta	N/A
Avg. Volume	1.8M
PE Ratio	96.75

52-Week High	2,488.00
52-Week Low	917.95
Market Capitalization	1.32T
EPS (Annual)	16.47
Price to Book	21.40
Revenue Per Employee	4.93M

Feed

News

Sentiment

Earnings

Fundamentals

Info

LAURUSLABS.NSE Fundamentals